Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123840242 | 12384024 | 2 | F | 20150213 | 20160624 | 20160519 | 20160705 | EXP | US-009507513-1605USA007713 | MERCK | 79.00 | YR | M | Y | 87.17000 | KG | 20160705 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123840242 | 12384024 | 1 | PS | JANUMET | METFORMIN HYDROCHLORIDESITAGLIPTIN PHOSPHATE | 1 | Oral | 1 DF, DAILY | Y | 22044 | 1 | DF | FILM-COATED TABLET | QD | |||||
| 123840242 | 12384024 | 2 | SS | GLIPIZIDE. | GLIPIZIDE | 1 | 10 MG, BID | U | U | 0 | 10 | MG | BID | ||||||
| 123840242 | 12384024 | 3 | SS | INVOKANA | CANAGLIFLOZIN | 1 | Oral | 300 MG, QD | Y | 0 | 300 | MG | QD | ||||||
| 123840242 | 12384024 | 4 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | U | 0 | |||||||||||
| 123840242 | 12384024 | 5 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | U | 0 | |||||||||||
| 123840242 | 12384024 | 6 | C | OSTEO | CHONDROITIN SULFATE (BOVINE)GLUCOSAMINE SULFATE | 1 | U | 0 | |||||||||||
| 123840242 | 12384024 | 7 | C | TUMS | CALCIUM CARBONATE | 1 | U | 0 | |||||||||||
| 123840242 | 12384024 | 8 | C | MICROZIDE (gliclazide) | 2 | U | 0 | ||||||||||||
| 123840242 | 12384024 | 9 | C | AVAPRO | IRBESARTAN | 1 | U | 0 | |||||||||||
| 123840242 | 12384024 | 10 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | U | 0 | |||||||||||
| 123840242 | 12384024 | 11 | C | FLOMAX | TAMSULOSIN HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 123840242 | 12384024 | 12 | C | THERAGRAN TABLETS ADVANCED FORMULA | 2 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123840242 | 12384024 | 1 | Diabetes mellitus |
| 123840242 | 12384024 | 3 | Diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123840242 | 12384024 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123840242 | 12384024 | Hypoglycaemia | |
| 123840242 | 12384024 | Hypophagia | |
| 123840242 | 12384024 | Oropharyngeal pain | |
| 123840242 | 12384024 | Renal impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |